Skip to main content
Fig. 3 | Allergy, Asthma & Clinical Immunology

Fig. 3

From: Real-world association between systemic corticosteroid exposure and complications in US patients with severe asthma

Fig. 3

Odds of acute SCS-related complications during the follow-up period due to SCS exposure. Prednisone-equivalent SCS dose; *p-value < 0.05; †from multivariate GEE models adjusting for patient demographics/baseline clinical characteristics (see Methods for covariates). CI, confidence interval; GEE, generalized estimating equations; OR, odds ratio; SCS, systemic corticosteroid; SD standard deviation

Back to article page

Allergy, Asthma & Clinical Immunology

ISSN: 1710-1492

Contact us